Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Old and new tests: where will it end?

P V Holland1

  • 1Sacramento Medical Foundation Blood Centers, CA 95816-7089, USA. abotogo@ns.net

Vox Sanguinis
|August 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.

Vox sanguinis·2010
Same author

Does donating blood for the first time during a national emergency create a better commitment to donating again?

Vox sanguinis·2009
Same author

TRALI is due to pulmonary venule damage from leucocytes with cholesterol crystal formation.

Vox sanguinis·2009
Same author

Transfusion-associated graft-versus-host disease.

Vox sanguinis·2008
Same author

Selling blood vs. donating blood.

Vox sanguinis·2008
Same author

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.

Transfusion·2005

Blood supply safety is enhanced by serologic and nucleic acid testing, alongside volunteer donors. Microbial inactivation offers an alternative to further testing for transfusion-transmitted infections.

Area of Science:

  • Blood Transfusion Safety
  • Infectious Disease Transmission
  • Medical Laboratory Science

Background:

  • The blood supply has significantly improved safety through various screening mechanisms.
  • Current strategies include serologic tests and nucleic acid testing (NAT) to detect viral infections during the pre-seroconversion window period.
  • Volunteer, unpaid blood donation is a critical factor in blood supply safety.

Purpose of the Study:

  • To evaluate the effectiveness of current and emerging strategies for ensuring blood supply safety.
  • To discuss the role of microbial inactivation technology as an alternative to additional donor screening.
  • To assess the potential risks and benefits of implementing new screening tests, such as for spongiform encephalopathies.

Main Methods:

Related Experiment Videos

  • Review of existing blood safety protocols, including serologic and nucleic acid-based testing.
  • Analysis of the impact of volunteer blood donation on reducing transfusion-transmitted infections.
  • Evaluation of microbial inactivation technologies for blood components.
  • Assessment of the theoretical risks associated with spongiform encephalopathy testing in blood donors.

    • Main Results:

    • Excellent safety has been achieved through current testing and donor screening methods.
    • Nucleic acid testing (NAT) is being implemented to identify carriers during the pre-seroconversion window period.
    • Microbial inactivation technology presents a promising alternative for further risk reduction, though not risk-free.
    • Implementing new tests, like those for spongiform encephalopathies, may introduce donor harm and reduce blood availability.

    Conclusions:

    • While testing has greatly enhanced blood safety, residual risks remain.
    • Microbial inactivation technology offers a viable strategy to further mitigate transfusion-transmitted infections.
    • The implementation of new screening tests requires careful consideration of potential harms, including donor safety and blood supply adequacy.